fashion -WSS

fashion

author：Wikipedia 2025-09-28 22:53:36 - browse：5338

A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Nobel honors Karikó and Weissman's enduring partnership

WSS

RSV injection headlines need to be accurate for good uptake

Experts study whether long Covid risk adds up with each reinfection

Fetal surgery at risk from Dobbs and new abortion restrictions

BIO selects John Crowley as new CEO

Fetal surgery at risk from Dobbs and new abortion restrictions

IVG is promising — but it won’t replace IVF quite yet

hotspot

fashion

explore

Supreme Court strikes down use of affirmative action

ReNAgade cuts staff seven months after raising $300 million

Medical records are filled with copy

Congress extends some pandemic preparedness programs

Peter Hotez and the public health issue of online harassment

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Drug repurposing or repositioning? The language matters

European officials brace for rough respiratory virus season

What does generative AI mean for health care? We asked experts

U.K. Biobank has 500,000 peoples' genome sequences available

focus

Will the market for weight loss drugs really reach $100 billion?

Setback for rare diseases as Taysha Gene Therapies pulls back

The United States is paying nearly triple for new Covid vaccines

Despite FDA concern, risk that CAR

Takeda, Janssen join wearable maker to measure scratching

Congress extends some pandemic preparedness programs

knowledge

Wikipedia

explore

focus